It is not clear whether this methodology shows efficacy in MPS IIIC where the defective enzyme is a transmembrane protein; however, the wild type (WT) brain macrophages/microglia derived from the transplanted HSPC could potentially mitigate neuroinflammatory response. Here, PSMA7 is linked to mucopolysaccharidosis type 3C.